Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2026 Earnings Call Transcript

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2026 Earnings Call Transcript May 7, 2026

Ginkgo Bioworks Holdings, Inc. misses on earnings expectations. Reported EPS is $-1.39 EPS, expectations were $-1.21115.

A close up of a laboratory beaker filled with colorful chemicals, signifying the company's specialty chemicals.

Follow Genentech Inc (NYSE:DNA)